SYNCOM FORMULATIONS (INDIA)
Back to Cashflow Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2017 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-18 Cr | ₹83 Cr | ₹-45 Cr | ₹-27 Cr | ₹-18 Cr |
What is the latest Cash Flow from Investing Activities ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹-18 Cr |
| Mar2024 | ₹83 Cr |
| Mar2023 | ₹-45 Cr |
| Mar2022 | ₹-27 Cr |
| Mar2017 | ₹-18 Cr |
How is Cash Flow from Investing Activities of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-18 Cr | Negative | |
| Mar2024 | ₹83 Cr | Positive | |
| Mar2023 | ₹-45 Cr | Negative | |
| Mar2022 | ₹-27 Cr | Negative | |
| Mar2017 | ₹-18 Cr | - | |
Compare Cash Flow from Investing Activities of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹1,905.4 Cr | 1% | 50.8% | 21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | 1% |
50.8% |
21.4% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses